Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome)

Clinical Endocrinology

Volumn 54, Issue 6, 2001, Pages 725-730

  Inglis, Gordon C ^b   Plouin, Pierre F ^a   Friel, Elaine C ^b   Davies, Eleanor ^b   Fraser, Robert ^b   Connell, John M C ^b  

^a HÔPITAL BROUSSAIS   (France)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; GENOMIC DNA; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ALDOSTERONE RELEASE; ARTICLE; BINDING SITE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HORMONE SYNTHESIS; HUMAN; INTRON; MALE; MUTATION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0035725546     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01287.x     Document Type: Article

References (30)

1. The nuclear receptor SF-1 (steroidogenic factor-1) is no longer an orphan
2. Pro-opiomelanocortin and adrenal function
3. Clonal composition of human adrenocortical neoplasms
4. Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism
5. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements
6. 2) receptor gene are not present in aldosterone-producing adenoma
7. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2
8. Primary hyperaldosteronism: Conn's syndrome and similar disorders
9. Cellular origins of aldosteronomas
10. Dissection of silencer elements in first intron controlling the human renin gene
11. Recent advances in the pathogenesis of adrenocortical tumours
12. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism
13. Aldosterone synthase gene in patients suffering from hyperaldoasteronism
14. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension
15. Lys173 and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension
16. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes
17. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function
18. In vivo MR spectroscopic imaging of the adrenal glands: Distinction between adenomas and carcinomas larger than 15 mm based on lipid content
19. Mutations of the p53 gene in human functional neoplasms
20. CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism
21. Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes
22. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population
23. Mutations in CYP11B1 gene converting 11β-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas
24. Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism
25. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms
26. p53 mutations in adrenal tumours: Caucasian patients do not show the exon 4 'hot spot' found in Taiwan
27. Primary aldosteronism. Part 1 Diagnosis of primary hyperaldosteronism
28. Primary aldosteronism. Part 2. Differential diagnosis of primary hyperaldosteronism and pseudoaldosteronism
29. Body elemental composition, with particular reference to total and exchangeable sodium, potassium and total chlorine, in untreated and treated primary hyperaldosteronism
30. Steroidogenic acute regulatory protein mRNA expression in adrenal tumours